Side effects in some patients include diarrhea, nausea, liver toxicity, and bone mineral density loss. By 2015, Truvada® had the largest market share (17%) of all HIV drugs with no competing HIV drugs on the market for prophylaxis. The potential market for PrEP is estimated as 1.2 ...